These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 25188300)

  • 1. Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.
    Leblond CS; Nava C; Polge A; Gauthier J; Huguet G; Lumbroso S; Giuliano F; Stordeur C; Depienne C; Mouzat K; Pinto D; Howe J; Lemière N; Durand CM; Guibert J; Ey E; Toro R; Peyre H; Mathieu A; Amsellem F; Rastam M; Gillberg IC; Rappold GA; Holt R; Monaco AP; Maestrini E; Galan P; Heron D; Jacquette A; Afenjar A; Rastetter A; Brice A; Devillard F; Assouline B; Laffargue F; Lespinasse J; Chiesa J; Rivier F; Bonneau D; Regnault B; Zelenika D; Delepine M; Lathrop M; Sanlaville D; Schluth-Bolard C; Edery P; Perrin L; Tabet AC; Schmeisser MJ; Boeckers TM; Coleman M; Sato D; Szatmari P; Scherer SW; Rouleau GA; Betancur C; Leboyer M; Gillberg C; Delorme R; Bourgeron T
    PLoS Genet; 2014 Sep; 10(9):e1004580. PubMed ID: 25188300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHANK1 Deletions in Males with Autism Spectrum Disorder.
    Sato D; Lionel AC; Leblond CS; Prasad A; Pinto D; Walker S; O'Connor I; Russell C; Drmic IE; Hamdan FF; Michaud JL; Endris V; Roeth R; Delorme R; Huguet G; Leboyer M; Rastam M; Gillberg C; Lathrop M; Stavropoulos DJ; Anagnostou E; Weksberg R; Fombonne E; Zwaigenbaum L; Fernandez BA; Roberts W; Rappold GA; Marshall CR; Bourgeron T; Szatmari P; Scherer SW
    Am J Hum Genet; 2012 May; 90(5):879-87. PubMed ID: 22503632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHANK1 polymorphisms and SNP-SNP interactions among SHANK family: A possible cue for recognition to autism spectrum disorder in infant age.
    Qiu S; Li Y; Bai Y; Shi J; Cui H; Gu Y; Ren Y; Zhao Q; Zhang K; Lu M; Wang Y; Li Y; Zhong W; Zhu X; Liu Y; Cheng Y; Qiao Y; Liu Y
    Autism Res; 2019 Mar; 12(3):375-383. PubMed ID: 30629339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.
    Berkel S; Marshall CR; Weiss B; Howe J; Roeth R; Moog U; Endris V; Roberts W; Szatmari P; Pinto D; Bonin M; Riess A; Engels H; Sprengel R; Scherer SW; Rappold GA
    Nat Genet; 2010 Jun; 42(6):489-91. PubMed ID: 20473310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of SHANK genes in neuropsychiatric disorders.
    Guilmatre A; Huguet G; Delorme R; Bourgeron T
    Dev Neurobiol; 2014 Feb; 74(2):113-22. PubMed ID: 24124131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling autism by SHANK gene mutations in mice.
    Jiang YH; Ehlers MD
    Neuron; 2013 Apr; 78(1):8-27. PubMed ID: 23583105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between NLGN3, NLGN4, SHANK2 and SHANK3 gene variants and autism spectrum disorder in a Chinese population.
    Liu Y; Du Y; Liu W; Yang C; Liu Y; Wang H; Gong X
    PLoS One; 2013; 8(2):e56639. PubMed ID: 23468870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci.
    Chilian B; Abdollahpour H; Bierhals T; Haltrich I; Fekete G; Nagel I; Rosenberger G; Kutsche K
    Clin Genet; 2013 Dec; 84(6):560-5. PubMed ID: 23350639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untreated PKU patients without intellectual disability:
    Klaassen K; Djordjevic M; Skakic A; Kecman B; Drmanac R; Pavlovic S; Stojiljkovic M
    Mol Genet Metab Rep; 2021 Dec; 29():100822. PubMed ID: 34900593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHANK proteins: roles at the synapse and in autism spectrum disorder.
    Monteiro P; Feng G
    Nat Rev Neurosci; 2017 Mar; 18(3):147-157. PubMed ID: 28179641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.
    Leblond CS; Heinrich J; Delorme R; Proepper C; Betancur C; Huguet G; Konyukh M; Chaste P; Ey E; Rastam M; Anckarsäter H; Nygren G; Gillberg IC; Melke J; Toro R; Regnault B; Fauchereau F; Mercati O; Lemière N; Skuse D; Poot M; Holt R; Monaco AP; Järvelä I; Kantojärvi K; Vanhala R; Curran S; Collier DA; Bolton P; Chiocchetti A; Klauck SM; Poustka F; Freitag CM; Waltes R; Kopp M; Duketis E; Bacchelli E; Minopoli F; Ruta L; Battaglia A; Mazzone L; Maestrini E; Sequeira AF; Oliveira B; Vicente A; Oliveira G; Pinto D; Scherer SW; Zelenika D; Delepine M; Lathrop M; Bonneau D; Guinchat V; Devillard F; Assouline B; Mouren MC; Leboyer M; Gillberg C; Boeckers TM; Bourgeron T
    PLoS Genet; 2012 Feb; 8(2):e1002521. PubMed ID: 22346768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology.
    Berkel S; Tang W; Treviño M; Vogt M; Obenhaus HA; Gass P; Scherer SW; Sprengel R; Schratt G; Rappold GA
    Hum Mol Genet; 2012 Jan; 21(2):344-57. PubMed ID: 21994763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders.
    Grabrucker AM
    Dev Neurobiol; 2014 Feb; 74(2):136-46. PubMed ID: 23650259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHANK1 and autism spectrum disorders.
    Gong X; Wang H
    Sci China Life Sci; 2015 Oct; 58(10):985-90. PubMed ID: 26335738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
    Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
    Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.
    Grabrucker S; Jannetti L; Eckert M; Gaub S; Chhabra R; Pfaender S; Mangus K; Reddy PP; Rankovic V; Schmeisser MJ; Kreutz MR; Ehret G; Boeckers TM; Grabrucker AM
    Brain; 2014 Jan; 137(Pt 1):137-52. PubMed ID: 24277719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice.
    Mossa A; Pagano J; Ponzoni L; Tozzi A; Vezzoli E; Sciaccaluga M; Costa C; Beretta S; Francolini M; Sala M; Calabresi P; Boeckers TM; Sala C; Verpelli C
    Mol Psychiatry; 2021 Jun; 26(6):1928-1944. PubMed ID: 33402706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders.
    Sala C; Vicidomini C; Bigi I; Mossa A; Verpelli C
    J Neurochem; 2015 Dec; 135(5):849-58. PubMed ID: 26338675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders.
    Schmeisser MJ
    Ann Anat; 2015 Jul; 200():115-7. PubMed ID: 25917711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro zinc supplementation alters synaptic deficits caused by autism spectrum disorder-associated Shank2 point mutations in hippocampal neurons.
    Vyas Y; Jung Y; Lee K; Garner CC; Montgomery JM
    Mol Brain; 2021 Jun; 14(1):95. PubMed ID: 34167580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.